Monday, December 26, 2011

Medication and Supplement Alert

Medication

Label Changes
There were too many to list, so if you go to this link, you can quickly see if one or more of your medication labels have been changed recently.

Antidepressants
Three new studies further shoot holes into the efficacy of antidepressants. In one study from Evidence Based Mental Health,
the evidence did not show a clinically important effect of antidepressants for individuals who have minor depression. There is no available evidence that assesses benzodiazepines for individuals for minor depression; therefore it is not possible to determine their role in this condition.

The other study suggests that
some depressed people do worse on antidepressants. Up to a fifth of patients being treated for depression with some medications may do worse than those given a placebo, according to findings in Archives of General Psychiatry.

In the third study from Future Neurology, despite their status as the current treatment of choice for depressive and anxiety disorders in children and adolescents, many questions remain concerning the efficacy and safety of SSRIs in this population. According to researchers, given the malleability of the adolescent brain to environmental stimuli, exposure to psychotropic drugs during this developmental period can have unexpected short-term and enduring neural consequences.

Atrial Fibrillation
The FDA is revising their label for Multaq because it doubled the risk of heart-related complications in patients with permanent atrial fibrillation, a condition in which the heart's chambers pump out of sync. The revised label stresses that Multaq is only approved for the short-term form of the condition and a related ailment known as atrial flutter. The label, written in cooperation with drugmaker Sanofi, instructs doctors to check patients' heart rhythm at least once every three months. If patients appear to have the permanent form of atrial fibrillation, Multaq should be discontinued.

Birth Control
A Bayer AG unit withheld from U.S. regulators findings by company researchers of increased reports of blood clots in users of its Yasmin birth-control pills, the former head of the Food and Drug Administration said. David Kessler, the former FDA commissioner, in a document unsealed recently in federal court, said Bayer didn't include an analysis “that demonstrated an increase in the U.S. reporting rate” for venous thromboembolism, or clots, in a 2004 review of Yasmin's safety provided to the agency. The FDA is now considering safety findings on Yasmin and its sister product Yaz.

Erectile Dysfunction
Men taking multiple medications for different health conditions may have a higher risk of erectile dysfunction -- a new British Journal of Urology International study of 37,700 men finds. Researchers found that those on three or more medications had higher rates of ED. Overall, 16% of men on no more than two drugs reported moderate ED -- meaning they "sometimes" had trouble getting or maintaining an erection. That compared with 20% of men on three to five medications, a quarter of men on six to nine drugs and 31% of those on at least 10 drugs.

Glucocorticoids
The use of inhaled glucocorticoids during pregnancy increases the risk for endocrine and metabolic disturbances, according to the American Journal of Respiratory and Critical Care Medicine. In the offspring of women who used inhaled glucocorticoids during pregnancy, there was a significantly increased risk for endocrine and metabolic disorders during childhood, compared with the offspring of the mothers who did not use inhaled glucocorticoids. Researchers suspect that a portion of inhaled glucocorticoids might cross the placenta and enter the fetus through the systemic circulation. Synthetic glucocorticoids might also secondarily affect the fetus by altering maternal physiology.


Pain Relievers
Available evidence linking acetaminophen and asthma for an article published in Pediatrics looked at more than half a million children at 122 centers in 54 countries. About 200,000 kids were 6 to 7 years old, and 320,000 were between 13 and 14 years old. In children who took acetaminophen more than once a year, but less than once a month, the risk of current asthma was 61 percent higher in the 6 to 7 year olds. For these young children who took acetaminophen more than once a month, the risk of having asthma more than tripled. The older children fared slightly better with an increased risk of 43 percent in those who took the drug more than once a year, but less than once a month. For those who took acetaminophen more than once a month, the risk of having asthma increased by 2.5 times. The researchers calculated that if acetaminophen exposure was eliminated in that teen group, the rate of severe asthma symptoms would decline by 43 percent.

Pneumonia
A study of US military veterans gives some more credence to a connection between exposure to proton pump inhibitors (PPI) and the risk of community-acquired pneumonia (CAP). In the Clinical Infectious Diseases study, researchers linked pharmacy and administrative databases of the New England Veterans Healthcare System to identify 1,544 patients who developed CAP after starting PPI therapy. Their analysis showed that PPI use was associated with a 30% increase in CAP.

Statins
Statin treatment may be associated with adverse effects on glucose metabolism. The aim of an International Journal of Clinical Practice study was to compare the effects simvastatin 40 mg, rosuvastatin 10 mg, or simvastatin/ezetimibe 10/10 mg for 12 weeks. The primary end point was changes in insulin resistance, fasting insulin levels, fasting plasma glucose, glycosylated haemoglobin, HOMA of b-cell function (HOMA-B), LDL-C, and high sensitivity C reactive protein (hsCRP). All three treatment regimens were associated with significant adverse increases in HOMA-IR and fasting insulin levels.


Urinary Tract Symptoms in Men
Common medications may account for 10% of all lower urinary tract symptoms (LUTS) in men. Various classes of prescription drugs are known to contribute to LUTS, but doctors may neglect to take the effects of these medications into account. A study published recently in BJU International researchers looked for associations between six classes of medications and LUTS in men with and without benign prostate hyperplasia (BPH). Antihistamines, bronchodilators, sympathomimetics, anticholinergics, diuretics, and antidepressants were all associated with LUTS, the strongest associations being bronchodilators and antidepressants. Overall, men taking any of the medications (versus none) were 29% more likely to have LUTS.

Dietary Supplements

Eclectic Institute
Voluntarily recalls specific dietary supplements containing Gotu Kola (Centella Asiatica) and Bladderwrack (Fucus Vesiculosus) because of possible salmonella contamination.


Germanium

The U.S. Army is investigating the deaths of two U.S. soldiers possibly linked to the popular pre-workout supplement Jack3d from USPlabs. Toxicology tests performed on the bodies revealed the presence of DMAA (1,3 dimethylamylamine) in their blood, according to an article in Stars and Stripes. DMAA—aka methylhexaneamine (MHA); aka geranium oil/stem/extract—is the infamous, supposedly natural, active ingredient in Jack3d, and has been linked to possible risk of liver damage and heart failure.

Plant-Based Supplements
Plant-based food supplements may contain compounds, like the so called alkenylbenzenes, that are of concern for human health. At high doses these chemical compounds can cause liver cancer in experimental animals. A new study, published in the last issue of the journal Food and Nutrition Sciences, reveals that in some plant-based food supplements levels of these compounds are so low that they are of no concern. Although there are also plant-based food supplements on the market that contain alkenylbenzenes at levels comparable to those causing tumors in laboratory animals.

The researchers selected thirty botanical compounds that are of possible concern for human health because they are able to damage the genetic material and/or are carcinogenic. The majority of these compounds were found to belong to the group of the alkenylbenzenes or the group of pyrrolizidine alkaloids. The analysis of several plant-based food supplements containing as main ingredient basil, fennel, nutmeg, sassafras, cinnamon or calamus or their essential oils revealed that some of these products contain relatively high levels of alkenylbenzenes. The researchers concluded that the use of such plant-based food supplements raises a concern for human health and might be of high priority for risk management actions to be taken.

Sport Beans
Sport Beans are becoming a popular alternative to energy and sports drinks. Sport Beans are jelly beans with added ingredients such as B vitamins (vitamins B1, B2, and B3), vitamin C, and potassium. Extreme Sport Beans also contain 50 mg of caffeine per 1 oz serving. But do they actually improve performance? Preliminary research suggests a very modest benefit in trained athletes compared to drinking plain water. They are full of sugar, so eating vitamin-infused candy before a workout is probably not the best choice.

No comments:

Post a Comment